Cargando…
Exploiting monocarboxylate transporters as new molecular targets for colorectal carcinoma therapy
Autores principales: | Amorim, Ricardo, Martins, Sandra, Longatto-Filho, Adhemar, Preto, Ana, Baltazar, Fátima |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3624101/ http://dx.doi.org/10.1186/1753-6561-7-S2-P60 |
Ejemplares similares
-
Expression of Monocarboxylate Transporters 1, 2, and 4 in Human Tumours and Their Association with CD147 and CD44
por: Pinheiro, Céline, et al.
Publicado: (2010) -
Monocarboxylate Transporters 1 and 4 Are Associated with CD147 in Cervical Carcinoma
por: Pinheiro, Céline, et al.
Publicado: (2009) -
Clinical impact of the metabolic phenotype of prostate cancer: role of monocarboxylate transporters (MCTs)
por: Pértega-Gomes, Nelma, et al.
Publicado: (2013) -
Reprogramming energy metabolism and inducing angiogenesis: co-expression of monocarboxylate transporters with VEGF family members in cervical adenocarcinomas
por: Pinheiro, Céline, et al.
Publicado: (2015) -
Significance of glycolytic metabolism-related protein expression in colorectal cancer, lymph node and hepatic metastasis
por: Martins, Sandra Fernandes, et al.
Publicado: (2016)